1. Home
  2. TMS vs OCGN Comparison

TMS vs OCGN Comparison

Compare TMS & OCGN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Teamshares Inc. Common Stock

TMS

Teamshares Inc. Common Stock

HOLD

Current Price

$5.50

Market Cap

482.4M

Sector

N/A

ML Signal

HOLD

Logo Ocugen Inc.

OCGN

Ocugen Inc.

HOLD

Current Price

$0.83

Market Cap

474.8M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
TMS
OCGN
Founded
2019
2013
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
482.4M
474.8M
IPO Year
2025
2014

Fundamental Metrics

Financial Performance
Metric
TMS
OCGN
Price
$5.50
$0.83
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
4
6
Target Price
★ $12.88
$12.17
AVG Volume (30 Days)
142.4K
★ 6.6M
Earning Date
11-24-2026
11-04-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
★ N/A
Revenue
N/A
N/A
Revenue This Year
$41.62
$12.33
Revenue Next Year
$70.99
$10.95
P/E Ratio
★ N/A
N/A
Revenue Growth
★ N/A
N/A
52 Week Low
$5.04
$0.79
52 Week High
$10.42
$2.73

Technical Indicators

Market Signals
Indicator
TMS
OCGN
Relative Strength Index (RSI) 35.70 28.10
Support Level $5.31 N/A
Resistance Level $9.58 $1.12
Average True Range (ATR) 0.67 0.06
MACD -0.25 -0.01
Stochastic Oscillator 17.96 11.94

Price Performance

Historical Comparison
TMS
OCGN

About TMS Teamshares Inc. Common Stock

Teamshares Inc is a tech-enabled company that acquires and operates small and medium-sized businesses. It uses a software platform to support activities across the acquisition lifecycle, including sourcing, evaluation, and transaction execution. After acquisition, the platform is used to integrate financial and operational data and to monitor performance across its portfolio companies. The company has two reportable segments: Small Business Acquisitions and Real Estate. The majority of revenue is derived from the Small Business Acquisitions, which includes all of the Operating Subsidiaries owned by the company.

About OCGN Ocugen Inc.

Ocugen Inc company focused on discovering, developing, and commercializing novel gene and cell therapies and vaccines that improve health and offer hope for patients across the globe. The company's pipeline includes Modifier Gene Therapy Platform, Novel Biologic Therapy for Retinal Diseases, Regenerative Medicine Cell Therapy Platform, Inhaled Mucosal Vaccine Platform. The company is developing a modifier gene therapy platform designed to fulfill unmet medical needs related to retinal diseases, including inherited retinal diseases ("IRDs"), such as RP, LCA, Stargardt disease, and multifactorial diseases such as dAMD and Geographic Atrophy ("GA").

Share on Social Networks: